Primary antiphospholipid syndrome presented as thrombotic microangiopathy in renal transplantation
Teresa Bada-Bosch(Hospital Universitario 12 De Octubre), Marina Alonso(Hospital Universitario 12 De Octubre), Natalia Polanco(Hospital Universitario 12 De Octubre), Ángel Sevillano(Hospital Universitario 12 De Octubre), Hernando Trujillo(Hospital Universitario 12 De Octubre), Beatríz Redondo(Universidad de Granada), Lucía Rodríguez(Hospital Universitario 12 De Octubre), Amado Andrés(Hospital Universitario 12 De Octubre), Pilar Auñón(Universidad Autónoma de Madrid)
Cited by 0
Related Papers
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
|The Lancet Diabetes & Endocrinology|2019|372
Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry
|European Heart Journal|2020|282
COVID-19 in transplant recipients: The Spanish experience
|American Journal of Transplantation|2020|200
Use of tocilizumab in kidney transplant recipients with COVID-19
|American Journal of Transplantation|2020|85
Fibroblast growth factor-23 promotes rhythm alterations and contractile dysfunction in adult ventricular cardiomyocytes
|Nephrology Dialysis Transplantation|2018|52